Results 141 to 150 of about 7,662 (216)

Chemical activation of the Piezo1 channel drives mesenchymal stem cell migration via inducing ATP release and activation of P2 receptor purinergic signaling [PDF]

, 2019
Fatema Mousawi, Hongsen Peng, Jing Li, Sreenivasan Ponnambalam, Sébastien Roger, Hucheng Zhao, Xuebin Yang, Lin‐Hua Jiang   +7 more
openalex   +1 more source

Purinergic Receptors Crosstalk with CCR5 to Amplify Ca2+ Signaling [PDF]

, 2020
Mizuho Horioka, Emilie Ceraudo, Emily Lorenzen, Thomas P. Sakmar, Thomas Huber   +4 more
openalex   +1 more source

The roles of purinergic signaling in psychiatric disorders.

, 2015
Marek Cieślak, Joanna Czarnecka, Katarzyna Roszek   +2 more
openalex   +2 more sources

Editorial: “Purinergic Signaling 2020: The State-of-The-Art Commented by the Members of the Italian Purine Club”

Frontiers in Pharmacology, 2021
Francisco Ciruela, Francisco Ciruela, Kjell Fuxe, Peter Illes, Peter Illes, Henning Ulrich, Henning Ulrich, Francesco Caciagli   +7 more
doaj   +1 more source

Purinergic signaling in inflammatory bowel disease

, 2019
Wei-Shang Hu, Sihui Li, Qiaofeng Wu
openalex   +1 more source

Two G protein-coupled receptors bind ceramides in atherosclerosis progression: targets for a new therapeutic strategy

Signal Transduction and Targeted Therapy
Yue Han, Peter Illes, Yong Tang
doaj   +1 more source

The role of the bladder urothelium as a chemical-neural transducer via purinergic signalling in the rapid defence against bacterial infection. [PDF]

Purinergic Signal, 2021
Chakrabarty B.
europepmc   +1 more source

Zebrafish models: Gaining insight into purinergic signaling and neurological disorders

, 2019
Débora Dreher Nabinger, Stefani Altenhofen, Carla Denise Bonan   +2 more
openalex   +2 more sources

Altered purinergic signaling in CD73‐deficient mice inhibits tumor progression [PDF]

, 2011
Gennady G. Yegutkin, Fumiko Marttila‐Ichihara, Marika Karikoski, Jussi Niemelä, Juha P. Laurila, Kati Elima, Sirpa Jalkanen, Marko Salmi   +7 more
openalex   +1 more source

Tumour initiated purinergic signalling promotes cardiomyocyte RBFOX1 degradation and cardiotoxicity from DNA damaging anticancer agents. [PDF]

Nat Commun
Tejay S, Lorenzana-Carrillo MA, Huang G, Tabatabaei Dakhili SA, Zhao Y-, Eaton F, Mendiola Pla M, Bowles DE, Kinnaird A, Paterson DI, Pituskin E, Ussher JR, Michelakis ED, Sutendra G.   +13 more
europepmc   +1 more source